SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-18-009655
Filing Date
2018-05-14
Accepted
2018-05-14 07:01:45
Documents
50
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20180331_10q.htm 10-Q 476183
2 EXHIBIT 10.4 ex_114043.htm EX-10.4 115847
3 EXHIBIT 31.1 ex_113689.htm EX-31.1 13697
4 EXHIBIT 31.2 ex_113690.htm EX-31.2 13711
5 EXHIBIT 32.1 ex_113691.htm EX-32.1 4806
6 EXHIBIT 32.2 ex_113692.htm EX-32.2 5057
13 ex_114043img001.jpg GRAPHIC 52856
  Complete submission text file 0001437749-18-009655.txt   2890280

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snbp-20180331.xml EX-101.INS 431591
8 XBRL TAXONOMY EXTENSION SCHEMA snbp-20180331.xsd EX-101.SCH 33989
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20180331_cal.xml EX-101.CAL 27057
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20180331_def.xml EX-101.DEF 237465
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20180331_lab.xml EX-101.LAB 201932
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20180331_pre.xml EX-101.PRE 252747
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 18828642
SIC: 2834 Pharmaceutical Preparations